Update in Blood Purification: EUPHRATES trial
Srisawat N, Tungsanga S, Lumlertgul N, Komaenthammasophon C, Peerapornratana S, Thamrongsat N, et al. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients. Crit Care. 2018 Oct 26; 22(1): 279.
Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshal JC, et al. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients with Septic Shock and Elevated Endotoxin Level. JAMA. 2018;320(14): 1455 - 1463.
Iba T and Fowler L. Is Polymyxin B-immobilized Fiber Column Ineffective for Septic Shock? Discussion on the Press Release for EUPHRATES Trial. J Intensive Care. 2017; 5:40.